RVTY revvity.com: Net earnings per share growth forecast for next year

Corporate emblem and logo of revvity.com (RVTY)

Revvity, Inc. (RVTY) focuses on high-margin biomedicine, implementing AI for drug discovery and gene therapy. The earnings per share growth projection for the next fiscal year shows that the parameter value is 9.80. Efficiency is maintained by outsourcing component production and logistics to external partners, while narrow technological specialization protects the company's market position from price competition.

RVTY: Revvity Corp Expected net earnings per share growth next year 02/21/2024 - 11/12/2026

Comprehensive metric breakdowns and analytics for revvity.com (RVTY)

- price and consensus price forecast:
Price Chart PerkinElmer|RVTY - Analyst Median Target
- company stock capitalization data:
Market Value Revvity|RVTY - Value Adjusted for Debt and Cash
- company book value details:
Book Value per Share Revvity|RVTY - Total Stockholders' Equity|Market Cap to Net Assets Ratio revvity.com|RVTY - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Revvity, Inc.|RVTY - Long-Term Debt to Equity|Short-Term Debt to Capital Revvity|RVTY - Company Total Debt Obligations|Debt to Book Value Revvity|RVTY - Amount of Long-Term Liabilities|Company Current Liabilities Revvity|Quick Liquidity Indicator revvity.com
- earnings and valuation multiples information:
RVTY - Final Profit|Projected Future Earnings Revvity, Inc.|RVTY - Business Payback Period|Future Price to Earnings Revvity, Inc.|RVTY - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Revvity|RVTY - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Revvity|RVTY - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months revvity.com|RVTY - Earnings per share increase in current year|Expected earnings per share growth for next year Revvity, Inc.
Initial company analysis:PerkinElmer
Brand item of revvity.com

Revvity, Inc. (RVTY) generates revenue through the supply of high-tech diagnostic systems and genomics reagents. This metric is calculated as the percentage change in expected earnings per share (EPS) between the current and the following fiscal year. This price action reflects market expectations regarding the monetization of innovations and the scaling of equipment sales. By analyzing the current consensus EPS growth forecast for the coming year, an investor can assess the business model's resilience to market volatility.

Direct competitors

Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Illumina, Inc. (ILMN)|EXAS (exactsciences.com) - Expected earnings per share trend next year|Earnings growth forecast for next year BIO (Bio-Rad)|Anbio Biotechnology Ltd (NNNN) - Expected net earnings per share growth next year|SHC: Expected earnings per share growth for next year|QDEL: Net earnings per share growth forecast for next year|OPK (OPKO Health, Inc.) - Expected earnings per share growth for next year|CDNA (CareDx) - Net earnings per share growth forecast for next year|MRVI (Maravai LifeSciences Holdings, Inc.) - Earnings growth forecast for next year|Fulgent Genetics Inc (FLGT) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year LAB (Fluidigm)|Projected earnings per share increase next year CTKB|OraSure Technologies - Expected earnings per share growth for next year|Exagen Inc (XGN) - Expected net earnings per share growth next year|MDXH: Expected earnings per share growth for next year|Expected earnings per share trend next year LUCD (Lucid Diagnostics, Inc.)|PRE: Earnings growth forecast for next year|IMDX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Trinity Biotech PLC|Projected earnings per share growth rate for next year PRPH (prophaselabs.com)|Earnings growth forecast for next year AIMD|Expected earnings per share growth for next year Co-Diagnostics Inc CODX|Heart Test Laboratories Inc. - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Biomerica Inc (BMRA)|CDIO - Net earnings per share growth forecast for next year|Expected earnings per share trend next year ONCO (onconetix.gcs-web.com)|VRAX (Virax Biolabs) - Expected earnings per share growth for next year|BJDX (Bluejay Diagnostics Inc) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year AWH|AXDX (Accelerate Diagnostics Inc) - Projected earnings per share increase next year|Expected earnings per share growth for next year CNTG (Centogene NV)|ENZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Fresh2 Group FRES|GENE - Expected earnings per share growth for next year|23andMe Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year Psychemedics Inc